Metadata
- Name
- A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT05194982
- Description
- In phase Ia study, the safety and tolerability of BL-B01D1 in patients with locally advanced
or metastatic solid tumor will be investigated to determine the dose-limiting toxicity (DLT),
maximum tolerated dose (MTD) of BL-B01D1.
In phase Ib study, the safety and tolerability of BL-B01D1 at the phase Ia recommended dose
will be further investigated, and recommended phase II dose (RP2D) for phase II clinical
studies will be determined.
In addition, the preliminary efficacy, pharmacokinetic characteristics, and immunogenicity of
BL-B01D1 in patients with locally advanced or metastatic solid tumor will be evaluated. - Data or Study Types
- clinical trial
- Keywords
- Small cell lung cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Nasopharyngeal cacinoma (NPC), Head and Neck Cancer (HNC)
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2022
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT05194982
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT05194982